In vivo and in vitro skin absorption of lipophilic compounds, dibutyl phthalate, farnesol and geraniol in the hairless guinea pig

Food and Chemical Toxicology

Volumn 48, Issue 1, 2010, Pages 18-23

  Doan, Khanh ^a   Bronaugh, Robert L ^a   Yourick, Jeffrey J ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

DBP; Farnesol; Geraniol; Hairless guinea pig; Percutaneous absorption; Skin

Indexed keywords

FARNESOL; GERANIOL; PHTHALIC ACID DIBUTYL ESTER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMULSION; EVAPORATION; FEMALE; GUINEA PIG; LIPOPHILICITY; NONHUMAN; PARTITION COEFFICIENT; SKIN ABSORPTION; SKIN PENETRATION; STRATUM CORNEUM;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DIBUTYL PHTHALATE; DIFFUSION; EMULSIONS; FARNESOL; FEMALE; GUINEA PIGS; SKIN ABSORPTION; SOLUBILITY; TERPENES;

CAVIA;

EID: 72449199374     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.09.002     Document Type: Article

References (25)

1. Bronaugh R.L., and Collier S.W. Protocol for in vitro percutaneous absorption studies. In: Bronaugh R., and Maibach H. (Eds). In vitro Percutaneous Absorption: Principles, Fundamentals, and Applications (1991), CRC Press Inc., Boca Raton, FL 237-241
2. Bronaugh R.L., and Stewart R.F. Methods for in vitro percutaneous absorption studies. J. Pharm. Sci. 74 1 (1986) 64-67
3. Buckley D.A. Fragrance ingredient labeling in products on sale in the UK. Brit. J. Dermatol. 157 (2007) 295-300
4. Cardullo A.C., Ruszkowski A.M., and DeLeo V.A. Allergic contact dermatitis resulting from sensitivity to citrus peel, geraniol, and citral. J. Am. Acad. Dermatol. 21 (1989) 395-397
5. Cater B.R., Cook M.W., Gangolli S.D., and Grasso P. Studies on di-butylphthalate induced testicular atrophy in the rat: effect on zinc metabolism. Toxicol. Appl. Pharm. 41 (1977) 609-618
6. Elsisi A.E., Carter D.E., and Sipes I.G. Dermal absorption of phthalate diesters in rats. Fund. Appl. Toxicol. 12 (1989) 70-77
7. Ema M., Amano H., and Ogawa Y. Characterization of the developmental toxicity of di-n-butylphthalate in rats. Toxicology 86 (1994) 163-174
8. Ema M., Kurosaka R., and Ogawa Y. Comparative developmental toxicity of n-butyl benzyl phthalate and di-n-butylphthalate in rats. Arch. Environ. Contam. Toxicol. 28 (1995) 223-228
9. Gildemeister, E., Hoffman, F., 1960. Die Atherischen Ole, 3a. Akademie-Verlag, Berlin, pp. 510-539.
10. Greif N. Cutaneous safety of fragrance materials as measured by the maximization test. Am. Perfum. Cosmet. 82 (1967) 54
11. Hagan E., Hansen W., Fitzhugh O.G., Jenner P.M., Jones W., Taylor I., Jean M., Eleanor L., Nelson A.A., and Brouwer J.B. Food flavourings and compounds of related structure: subacute and chronic toxicity. Food. Cosmet. Toxicol. 5 (1967) 141
12. Hood H.L., Wickett R.R., and Bronaugh R.L. The in vitro percutaneous absorption of the fragrance ingredient musk xylol. Food. Chem. Toxicol. 34 (1996) 483-488
13. Jain A.K., Thomas N.S., and Panchagnula R. Transdermal drug delivery of imipramine hydrochloride I. Effect of terpenes. J. Control. Release 79 (2004) 93-101
14. McKee R., Butala J., David R., and Gans G. NTP center for the evaluation of risks to human reproduction reports on phthalates: addressing the data gaps: selective review. Reprod. Toxicol. 18 (2004) 1-22
15. Nokhodchia A., Sharabianib K., Rashidibb M.R., and Ghafourian T. The effect of terpene concentrations on the skin penetration of diclofenac sodium. Int. J. Pharm. 335 (2007) 97-105
16. National Toxicology Program (NTP), 2000. Center for Evaluation of Risks to Human Reproduction, NTP-CERHR Expert Panel Report on Di-n-Butyl Phthalate, (NTP-ERHR-DBP-00). United States Department of Heath and Human Services, Research Triangle Park, North Carolina.
17. OECD (2004). OECD Guidelines for the Testing of Chemicals/Section 4: Health Effects Test No. 428: Skin Absorption: In Vitro Method, 23 Nov 2004. ISBN: 9789264071087, OECD Code: 979942801E1.
18. 14C]di-n-butylphthalate in rat. Drug. Metab. Dispos. 29 6 (2001) 843-854
19. SCCP, 2006. SCCP/1005/06: The SCCP'S Notes of Guidance for the Testing of Cosmetic Ingredients and their Safety Evaluation, adopted by the SCCP during the 10th plenary meeting of 19 December 2006.
20. Schnuch A., Uter W., Geier J., Lessmann H., and Frosch P.J. Contact allergy to farnesol in 2021 consecutively patch tested patients. Results of the IVDK. Contact Dermatitis 50 (2004) 117-121
21. Scott R.C., Dugard P.H., Ramsey J.D., and Rhodes C. In vitro absorption of o-phthalate diesters through human and rat skin. Environ. Health Persp. 74 (1987) 223-227
22. Srivastava S.P., Srivastava S., Saxena D.K., Chandra S.V., and Seth P.K. Testicular effects of di-n-butyl phthalate (DBP): biochemical and histopathological alterations. Arch. Toxicol. 64 (1990) 148-152
23. Tanaka A., Matsumoto A., and Yamaha T. Biochemical studies on phthalic esters. Metabolism of dibutyl phthalate (DBP) in animals. Toxicology 9 (1978) 109-123
24. Yourick J.J., Koenig M.L., Yourick D.L., and Bronaugh R.L. Fate of chemicals in skin after dermal application: does the in vitro skin reservoir affect the estimate of systemic absorption?. Toxicol. Appl. Pharm. 195 (2004) 309-320
25. Yourick J.J., Jung C.T., and Bronaugh R.L. In vitro and in vivo percutaneous absorption of retinol from cosmetic formulations: significance of the skin reservoir and prediction of systemic absorption. Toxicol. Appl. Pharm. 231 (2008) 117-121